I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| CD4-positive, alpha-beta T cell | 4 studies | 19% ± 2% | |
| classical monocyte | 4 studies | 24% ± 5% | |
| epithelial cell | 4 studies | 44% ± 12% | |
| endothelial cell | 4 studies | 24% ± 6% | |
| CD8-positive, alpha-beta T cell | 4 studies | 19% ± 3% | |
| natural killer cell | 4 studies | 21% ± 4% | |
| B cell | 3 studies | 22% ± 4% | |
| conventional dendritic cell | 3 studies | 35% ± 9% | |
| hematopoietic precursor cell | 3 studies | 29% ± 5% | |
| non-classical monocyte | 3 studies | 25% ± 7% | |
| fibroblast | 3 studies | 25% ± 9% | |
| ciliated cell | 3 studies | 28% ± 1% | |
| erythroblast | 3 studies | 28% ± 13% | |
| macrophage | 3 studies | 27% ± 7% | |
| glutamatergic neuron | 3 studies | 22% ± 5% | |
| dendritic cell | 3 studies | 42% ± 12% | |
| intestinal crypt stem cell | 3 studies | 20% ± 4% | |
| plasmacytoid dendritic cell | 3 studies | 22% ± 4% | |
| regulatory T cell | 3 studies | 16% ± 1% |
